Discovery of Potent and Selective Inhibitors of Monopolar Spindle 1 (MPS1) Kinase
Rob van Montfort, The Institute of Cancer Research, speaking at Discovery Chemistry Congress 2015.
Mass spectrometry based metabolomics in chemical and nanomaterial risk assessment
In this webinar, Mark Viant, Professor of Metabolomics at the University of Birmingham, will introduce the concepts of metabolomics as well as the challenges faced in chemical hazard assessment.
A Structured Approach to Academic Drug Discovery
Simon Ward, University of Sussex, speaking at Discovery Chemistry Congress 2015
Exploring Protein-protein Interactions Using Scaffolded and Assembled Peptides as Synthetic Binding Site Mimics
Jutta Eichler, University of Erlangen-Nuremberg, speaking at Discovery Chemistry Congress 2015.
Bioorthogonal Palladium-Labile Prodrugs for Site-Specific Anticancer Therapy
Asier Unciti-Broceta, University of Edinburgh, speaking at Discovery Chemistry Congress 2015.
Transporter Knockout Cell Lines in Preclincal Toxicology Assays and Services
Join this webinar to learn how advanced ADME and toxicology services can help in the efficient development of drugs.
Machine Learning for Building Models of Cell Perturbation
Robert Murphy, Carnegie Mellon University, speaking at Drug Discovery and Development 2014
What Can We Learn from Fragment Based Optimization Programs?
Gyorgy Keseru, Hungarian Academy of Sciences, speaking at Drug Discovery and Development 2014
Enabling New Pharma: Drug Re-purposing Efforts Go Mainstream. Innovative Alternatives for Stalled Pharmaceutical Pipelines
Rathnam Chaguturu, SRI International, speaking at Drug Discovery and Development 2014
Rising Role of Academic Drug Discovery
Barbara Slusher, Johns Hopkins University School of Medicine, speaking at Drug Discovery and Development 2014.
|<<|| 1 2 3 4 5 6 7 || >>|
|Showing Results 1 - 10 of 106|